Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is a prescription-only medicine in the UK, which means the only legal route to it is a clinical assessment by a qualified prescriber. No pharmacy can dispense it, and no website can sell it, without that step having taken place first. Understanding what that assessment covers, and what makes a prescriber say yes or no, is the practical starting point for anyone considering this treatment. Tirzepatide is licensed in the UK under the brand name Mounjaro, and it is available through private routes for adults who meet the clinical criteria, as the NHS medicines page for tirzepatide sets out.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is worth stating this plainly, because searches for tirzepatide without a prescription suggest some people hope there is a workaround. There isn't. Under the Human Medicines Regulations 2012, tirzepatide is classified as a Prescription-Only Medicine, and that classification is not a formality. It exists because the medicine has real effects on multiple body systems, interacts with other drugs, and is contraindicated in certain conditions. A prescriber's job is to catch the cases where those factors matter.
Sellers offering tirzepatide without a clinical assessment are operating illegally. The MHRA has been clear about this, and enforcement has been significant: around 20 million doses of illegally traded weight-loss medicines, worth roughly £45 million, were seized in 2025, including the first illicit UK manufacturing site producing counterfeit tirzepatide pens. Fake pens have in some cases contained insulin, with serious consequences for the people who used them. If you are wondering whether you can just buy Mounjaro without going through a clinical process, the short answer is that any site willing to supply without one is operating outside the law, and both an unusually low price and the absence of any clinical step are reasons to walk away and report the seller via the MHRA's Yellow Card service.
The full breakdown of tirzepatide's prescription-only status covers the regulatory detail if you want to go deeper.
The prescription decision for tirzepatide is a clinical one, shaped by your health record rather than a checklist. A few things prescribers consider:
BMI. The licensed threshold is 30 or above, or 27 or above where you have at least one qualifying weight-related condition. Lower thresholds apply for some ethnic backgrounds under UK guidance. But BMI alone doesn't settle the question either way.
Existing medical conditions. A personal or family history of medullary thyroid carcinoma or a condition called MEN2 rules out tirzepatide. Active or recent pancreatitis, certain gastrointestinal conditions, and some kidney or liver presentations all require careful weighing. Prescribers also consider whether you are pregnant, trying to conceive, or breastfeeding, because tirzepatide is not recommended in any of those situations.
Current medicines. Tirzepatide slows gastric emptying, which affects how quickly other medicines are absorbed. Women taking oral contraceptives are advised to add a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because pill absorption may be reduced. Those already on diabetes medicines, blood-pressure treatments or anticoagulants need that context reviewed too.
Thinking about how a Mounjaro prescription is issued in the UK can help clarify what the consultation actually covers.
This is often the decision that actually sits behind a search for tirzepatide prescription options, so it deserves a direct answer.
On the NHS, tirzepatide (Mounjaro) is available following the phased rollout described in NICE technology appraisal TA1026. Access is currently restricted to people with a BMI of 40 or above plus four or more of five specific conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes. From around June 2026, those criteria expand to include BMI 35–39.9 with four or more of those conditions. Further expansion follows in 2027. Even if you qualify, your GP practice needs to be participating, and wraparound dietary support is required. For most people, that means a wait.
Private treatment through a regulated online pharmacy removes the referral requirement and the waiting list, subject to clinical suitability. It does not remove the clinical assessment, it replaces the GP queue with a prescriber who reviews your consultation the same day. You can compare what private treatment typically costs to understand what the private route actually involves financially, including what is and isn't included in headline prices you might see elsewhere.
Order before 12pm on a weekday, and at nume, a GPhC-registered Independent Prescriber reviews your consultation that day. If approved, treatment is dispatched the same day and delivered free by DPD the next working day, in plain unbranded packaging. That's what the private route looks like when it's done properly.
Knowing that a prescription is required is only useful if you can identify a pharmacy that handles it properly. The check takes less than a minute. Every legal UK online pharmacy must be registered with the General Pharmaceutical Council. You can verify any pharmacy at the GPhC pharmacy register, where you can search by name or registration number. If a site isn't listed, or declines to give you its GPhC number, that is a clear warning sign.
Beyond registration, look at the consultation process itself. A legitimate prescriber reviews your answers personally, not via an automated scoring system. They ask about your medical history, current medicines and relevant conditions. They may ask for evidence of your current weight or previous treatment. That process takes a few minutes and might feel thorough. That's the point.
If you'd like to understand what a tirzepatide prescription route looks like end-to-end, the guide to whether you need a prescription for tirzepatide and the overview of how to buy tirzepatide through a regulated pharmacy both cover that ground. For a broader look at the treatment itself, the full Mounjaro treatment page is a good starting point. When you're ready, check your eligibility with our prescribers, the consultation is free.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.